Business
PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
About this update from Syntara Limited
[{"type":"text","content":"Syntara Limited has released a press release. View Attachment","length":230,"tagName":"div"}]